Altogether, the in vitro and in vivo data suggested that MP06 was partially associated with cancer stemness and EMT in H1299 cells and that suppressing AQP3 expression to target VEGF may be an effective anti-angiogenic therapy. The gene discussed is AQP3; the disease is cancer.